Adenocarcinoma Clinical Trials in Shanghai, Shanghai Municipality
53 recruitingShanghai, Shanghai Municipality, China
Showing 1–20 of 53 trials
Recruiting
Phase 3
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Rectal AdenocarcinomaColon Adenocarcinoma
Merck Sharp & Dohme LLC477 enrolled200 locationsNCT06997497
Recruiting
Phase 1Phase 2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Triple-Negative Breast CancerEndometrial CancerPrimary Peritoneal Carcinoma+12 more
Genmab884 enrolled66 locationsNCT05579366
Recruiting
Phase 2Phase 3
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
Pancreatic Ductal Adenocarcinoma
Bristol-Myers Squibb470 enrolled279 locationsNCT07076121
Recruiting
Phase 1
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Gastric CancerEndometrial CancerHepatocellular Carcinoma+5 more
Seagen, a wholly owned subsidiary of Pfizer714 enrolled61 locationsNCT05208762
Recruiting
Not Applicable
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
Lung Adenocarcinoma
Shanghai Pulmonary Hospital, Shanghai, China690 enrolled14 locationsNCT04937283
Recruiting
Phase 1
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Gastric CancerEsophageal AdenocarcinomaMetastatic Cancer+5 more
I-Mab Biopharma US Limited330 enrolled21 locationsNCT04900818
Recruiting
Phase 1Phase 2
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Colorectal, CancerBiliary Tract CancerPancreatic Ductal Adenocarcinoma
Merck Sharp & Dohme LLC220 enrolled55 locationsNCT06428409
Recruiting
Early Phase 1
A Study of GC203 TIL in PDCA (RJ)
Pancreatic CancerTreatment Side EffectsTumor Infiltrating Lymphocytes+1 more
Shanghai Juncell Therapeutics10 enrolled1 locationNCT06828328
Recruiting
Phase 2
Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy
Pancreatic Adenocarcinoma Locally Advanced
Ruijin Hospital20 enrolled1 locationNCT07306286
Recruiting
Phase 2
IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy
Pancreatic Adenocarcinoma Locally Advanced
Ruijin Hospital20 enrolled1 locationNCT07306273
Recruiting
Phase 1Phase 2
Study of GV20-0251 in Participants With Solid Tumor Malignancies
MelanomaNon-small Cell Lung CancerSolid Tumor Cancer+6 more
GV20 Therapeutics350 enrolled3 locationsNCT07070518
Recruiting
Phase 3
Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer
Pancreatic Adenocarcinoma
Fudan University210 enrolled1 locationNCT06250972
Recruiting
Lymph Node Pathologic Grading Strategy
Lung Adenocarcinoma
Fudan University2,998 enrolled1 locationNCT06745830
Recruiting
Phase 3
Segmentectomy for Solid-dominant Lung Cancer
Lung AdenocarcinomaSegmentectomy
Fudan University277 enrolled1 locationNCT06634966
Recruiting
Not Applicable
Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP)
Prostate AdenocarcinomaLocalized Prostate Carcinoma
Shanghai Changzheng Hospital480 enrolled1 locationNCT06238713
Recruiting
Phase 3
Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)
Lung AdenocarcinomaSegmentectomy
Fudan University307 enrolled1 locationNCT05717803
Recruiting
Phase 1
Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression
Pancreatic CancerGastric CancerGastroesophageal Junction Adenocarcinoma+1 more
Suzhou Immunofoco Biotechnology Co., Ltd30 enrolled1 locationNCT05472857
Recruiting
Phase 4
Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study
Non-small Cell Lung CancerCarcinomaAdenocarcinoma
Tian Xie744 enrolled7 locationsNCT04401059
Recruiting
Phase 3
Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)
Lung AdenocarcinomaFrozen SectionSublobar Resection
Fudan University390 enrolled1 locationNCT06031181
Recruiting
Phase 2
Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma
Lung Adenocarcinoma Stage IIILung Adenocarcinoma Stage IVEGFR Gene Mutation
Shanghai Pulmonary Hospital, Shanghai, China96 enrolled1 locationNCT05503667